#	Pagina
attuale pagina	/open-h2020/projects/213152/index.html

Opendata, web and dolomites

Drug the bug

Identification of novel inhibitors to prevent microbial production of pro-diabetic metabolites

Total Cost €

EC-Contrib. €

Partnership

Views

Drug the bug project word cloud

Explore the words cloud of the Drug the bug project. It provides you a very rough idea of what is the project "Drug the bug" about.

medication class mice imidazole bug enzyme propionate erc hepatocytes inhibitors histidine drug humans induce award explore diseases thereby gut consolidator injected microbiota bariatric metabolism insulin surgery altered capacity sensitivity diabetes envision improvements microbial reduce resistance metabolic urda linked interestingly poc demonstrated metabolite successful primary synthesized

Project "Drug the bug" data sheet

The following table provides information about the project.

Coordinator	GOETEBORGS UNIVERSITET Organization address address: VASAPARKEN city: GOETEBORG postcode: 405 30 website: www.gu.se contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Sweden [SE]
Total cost	149˙700 €
EC max contribution	149˙700 € (100%)
Programme	1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
Code Call	ERC-2017-PoC
Funding Scheme	ERC-POC
Starting year	2017
Duration (year-month-day)	from 2017-12-01 to 2019-05-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	GOETEBORGS UNIVERSITET GOETEBORGS UNIVERSITET Organization address address: VASAPARKEN city: GOETEBORG postcode: 405 30 website: www.gu.se contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (GOETEBORG)	coordinator	149˙700.00

Map

Project objective

The gut microbiota has been associated with metabolic diseases, such as type 2 diabetes. In my ERC consolidator award we demonstrated that the gut microbiota is altered following bariatric surgery and that the altered microbiota may be directly linked to some of the metabolic improvements observed following surgery. Interestingly, improved metabolism was associated with altered metabolite production capacity from the microbiota and we observed that a metabolite, imidazole propionate, was reduced after surgery. In associated projects we have demonstrated that imidazole propionate is associated with type 2 diabetes in humans and induce insulin resistance in primary hepatocytes and when injected into mice. Imidazole propionate is synthesized by the microbial enzyme UrdA from histidine. This POC will explore the potential of identifying inhibitors of UrdA to reduce production of imidazole propionate and thereby improve insulin sensitivity. If successful we envision a new class of diabetes medication based on the concept of drug the bug.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DRUG THE BUG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DRUG THE BUG" are provided by the European Opendata Portal: CORDIS opendata.